We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
-17.67%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$666M
AUM Growth
-$78.6M
(-11%)
Cap. Flow
+$47.8M
Cap. Flow
% of AUM
7.17%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Relay Therapeutics
RLAY
|
+$3.83M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$3M |
| 3 |
Teck Resources
TECK
|
+$2.87M |
| 4 |
MODV
ModivCare
MODV
|
+$2.67M |
| 5 |
Genpact
G
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.07M |
| 2 |
CHS
Chicos FAS, Inc.
CHS
|
+$2.68M |
| 3 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$2.45M |
| 4 |
Crane NXT
CXT
|
+$2.44M |
| 5 |
ATCO
Atlas Corp.
ATCO
|
+$2.27M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.12% |
| 2 | Technology | 15.11% |
| 3 | Consumer Discretionary | 12.76% |
| 4 | Industrials | 12.53% |
| 5 | Financials | 11.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Koppers
KOP
$969M
| $221K | 0.03% |
9,779
-12,437
| -56% | -$315K |
|
1027
Markel Group
MKL
$23.2B
| $220K | 0.03% |
+170
| New | +$233K |
|
1028
Monolithic Power Systems
MPWR
$68.9B
| $220K | 0.03% |
572
-616
| -52% | -$260K |
|
1029
Patria Investments
PAX
$1.86B
| $220K | 0.03% |
+16,678
| New | +$263K |
|
1030
M/I Homes
MHO
$3.84B
| $219K | 0.03% |
5,515
-4,047
| -42% | -$176K |
|
|
AVEO
1031
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $219K | 0.03% |
+33,410
| New | +$162K |
|
|
JHG
1032
DELISTED
Janus Henderson
JHG
| $218K | 0.03% |
+9,268
| New | +$266K |
|
1033
Cass Information Systems
CASS
$743M
| $216K | 0.03% |
6,381
-2,539
| -28% | -$91.2K |
|
1034
PTC
PTC
$16B
| $216K | 0.03% |
+2,028
| New | +$219K |
|
1035
AirSculpt Technologies
AIRS
$353M
| $215K | 0.03% |
+36,258
| New | +$341K |
|
|
API
1036
Agora
API
$377M
| $215K | 0.03% |
32,710
+22,052
| +207% | +$156K |
|
1037
Capitol Federal Financial
CFFN
$1.1B
| $215K | 0.03% |
+23,423
| New | +$231K |
|
|
KLRS
1038
Kalaris Therapeutics
KLRS
$96.8M
| $215K | 0.03% |
2,393
-1,658
| -41% | -$174K |
|
1039
Hyliion Holdings
HYLN
$690M
| $214K | 0.03% |
+66,512
| New | +$233K |
|
1040
Kinder Morgan
KMI
$68.7B
| $214K | 0.03% |
+12,768
| New | +$239K |
|
1041
Sight Sciences
SGHT
$412M
| $214K | 0.03% |
+23,802
| New | +$209K |
|
1042
Abercrombie & Fitch
ANF
$5B
| $213K | 0.03% |
+12,575
| New | +$347K |
|
1043
Fortinet
FTNT
$117B
| $213K | 0.03% |
+3,773
| New | +$224K |
|
1044
CrowdStrike
CRWD
$218B
| $212K | 0.03% |
5,036
-60
| -1% | -$2.72K |
|
1045
Passage Bio
PASG
$14.1M
| $212K | 0.03% |
4,485
+1,083
| +32% | +$50.6K |
|
1046
BorgWarner
BWA
$13.9B
| $211K | 0.03% |
+7,185
| New | +$237K |
|
|
ATCX
1047
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $211K | 0.03% |
+40,118
| New | +$380K |
|
1048
IMAX
IMAX
$2.66B
| $210K | 0.03% |
+12,439
| New | +$202K |
|
|
NBIS
1049
Nebius Group N.V.
NBIS
$47.7B
| $210K | 0.03% |
11,072
| – | – |
|
|
BGFV
1050
DELISTED
Big 5 Sporting Goods
BGFV
| $209K | 0.03% |
18,614
-41,417
| -69% | -$565K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2022 Portfolio in Review
As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.
- GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
- GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
- GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
- GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
- GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
- GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.
Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.